Timothy J. Eberlein, MD, FACS, a surgical oncologist from St. Louis, MO, was elected as the new Chair of the ACS Board of Regents following the Clinical Congress 2022 Annual Business Meeting of Members. In his role as Chair, Dr. Eberlein will work closely with Executive Director & CEO Patricia L. Turner, MD, MBA, FACS, and will chair the Finance and Executive Committees.
Dr. Eberlein is the Spencer T. and Ann W. Olin Distinguished Professor and senior associate dean for cancer programs at the Washington University School of Medicine and director of The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital, both in St. Louis.
Dr. Eberlein has been an ACS Fellow since 1988 and a member of the ACS Board of Regents since 2015. He has served as Editor-in-Chief of the Journal of the American College of Surgeons (JACS) since 2004. Under his editorial leadership, the impact factor of JACS has risen to the current record high 6.532, which Dr. Eberlein attributed to the researchers who publish their work in the journal. JACS now ranks 14th among the 211 journals in the surgery category.
A member of the ACS Academy of Master Surgeon Educators (2019), Dr. Eberlein’s service to the ACS has been extensive: he served on the ACS Board of Governors (2004–2010) as a specialty society Governor from the Society of Surgical Oncology, he has been a Member of the ACS Commission on Cancer (since 1995), and served as Vice-Chair of the ACS Committee for the Forum on Fundamental Surgical Problems (2000–2004). He also was extensively involved in the ACS Oncology Group (which merged with two other cooperative groups in 2011 to form the Alliance for Clinical Trials in Oncology), and the ACS Surgical Research and Education Committee, which he chaired (2000–2002).
Read more about Dr. Eberlein.
Dr. Anthony Atala Is Vice-Chair
In addition to Dr. Eberlein, Anthony Atala, MD, FACS, a pediatric urologist in Winston-Salem, NC, was elected as Vice-Chair of the Board of Regents.
Dr. Atala currently is the George Link Jr. Professor and director of the Wake Forest Institute for Regenerative Medicine (WFIRM) and the W. H. Boyce Professor and chair of Urology at the Wake Forest University School of Medicine.
Dr. Atala also is a researcher, professor, and mentor who is renowned for developing foundational principles for regenerative medicine research, which holds great promise for people who require tissue substitution and reconstruction. Dr. Atala and his team successfully implanted the world’s first laboratory-grown bladder in 1999. He received the prestigious 2022 ACS Jacobson Innovation Award earlier this year for his ongoing revolutionary work in regenerative medicine.
